1. Home
  2. TKNO vs LSAK Comparison

TKNO vs LSAK Comparison

Compare TKNO & LSAK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TKNO
  • LSAK
  • Stock Information
  • Founded
  • TKNO 1996
  • LSAK 1997
  • Country
  • TKNO United States
  • LSAK South Africa
  • Employees
  • TKNO N/A
  • LSAK N/A
  • Industry
  • TKNO Medicinal Chemicals and Botanical Products
  • LSAK Investment Bankers/Brokers/Service
  • Sector
  • TKNO Health Care
  • LSAK Finance
  • Exchange
  • TKNO Nasdaq
  • LSAK Nasdaq
  • Market Cap
  • TKNO 256.9M
  • LSAK 344.5M
  • IPO Year
  • TKNO 2021
  • LSAK N/A
  • Fundamental
  • Price
  • TKNO $4.35
  • LSAK $4.74
  • Analyst Decision
  • TKNO
  • LSAK
  • Analyst Count
  • TKNO 0
  • LSAK 0
  • Target Price
  • TKNO N/A
  • LSAK N/A
  • AVG Volume (30 Days)
  • TKNO 224.0K
  • LSAK 18.6K
  • Earning Date
  • TKNO 08-07-2025
  • LSAK 09-10-2025
  • Dividend Yield
  • TKNO N/A
  • LSAK N/A
  • EPS Growth
  • TKNO N/A
  • LSAK N/A
  • EPS
  • TKNO N/A
  • LSAK N/A
  • Revenue
  • TKNO $38,923,000.00
  • LSAK $574,080,000.00
  • Revenue This Year
  • TKNO $9.52
  • LSAK $1.06
  • Revenue Next Year
  • TKNO $15.20
  • LSAK $13.32
  • P/E Ratio
  • TKNO N/A
  • LSAK N/A
  • Revenue Growth
  • TKNO 11.40
  • LSAK 4.13
  • 52 Week Low
  • TKNO $4.00
  • LSAK $3.39
  • 52 Week High
  • TKNO $10.37
  • LSAK $5.60
  • Technical
  • Relative Strength Index (RSI)
  • TKNO 43.35
  • LSAK 51.59
  • Support Level
  • TKNO $4.22
  • LSAK $4.60
  • Resistance Level
  • TKNO $4.94
  • LSAK $4.76
  • Average True Range (ATR)
  • TKNO 0.29
  • LSAK 0.11
  • MACD
  • TKNO -0.00
  • LSAK -0.01
  • Stochastic Oscillator
  • TKNO 16.75
  • LSAK 36.73

About TKNO Alpha Teknova Inc.

Alpha Teknova Inc provides critical reagents that enable the discovery, development, and production of biopharmaceutical products such as drug therapies, novel vaccines, and molecular diagnostics. Its offer three product types: pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It derives key revenue from United States.

About LSAK Lesaka Technologies Inc.

Lesaka Technologies Inc provides payment solutions, transaction processing solutions, and financial technologies. The company operates two reportable segments: Merchant and Consumer. The company operates mainly within South Africa. The Merchant segment that derives majority revenue includes activities related to the provision of goods and services provided to corporate and other juristic entities. It earns fees from processing activities performed for its customers and revenue generated from the distribution of prepaid airtime. The Consumer segment includes activities related to the provision of financial services to customers, including bank accounts, loans, and insurance products. The firm charges monthly administration fees for all bank accounts.

Share on Social Networks: